FDA Approves SynGenX-1000 Cord Blood Processing Platform

Medindia Health News Medindia largest health website in india. // via fulltextrssfeed.com

FDA Approves SynGenX-1000 Cord Blood Processing Platform Jul 20th 2013, 07:13 A company that makes products for extracting stem cells from a variety of sources, SynGen Inc., of Sacramento, CA, has received the FDA nod for its SynGenX-1000 platform. The SynGenX-1000 platform is capable of harvesting stem cells from umbilical cord blood. Philip Coelho, CEO of SynGen, said "This 'next generation' SynGenX�-1000 System improves the recovery of stem and progenitor cells from cord blood units, which should increase the number of clinical grade units available for transplantation. The CryoPRO-2� simplifies the cryopreservation workflow for cord blood bank personnel and provides a medical record of the process. The SynGen� DataTrak software captures the data associated with processing each cord blood unit for the blood bank's records." Source-Medindia Do you like this Report? 0 0

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions